BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 29794869)

  • 41. Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor.
    Leão R; van Agthoven T; Figueiredo A; Jewett MAS; Fadaak K; Sweet J; Ahmad AE; Anson-Cartwright L; Chung P; Hansen A; Warde P; Castelo-Branco P; O'Malley M; Bedard PL; Looijenga LHJ; Hamilton RJ
    J Urol; 2018 Jul; 200(1):126-135. PubMed ID: 29474847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Retroperitoneal lymphadenectomy in disseminated non-seminoma germinogenic testicular tumors after chemotherapy in patients with elevated serum tumor markers].
    Matveev VB; Volkova MI; Cherniev VA; Figurin KM; Mitin AV
    Urologiia; 2010; (3):41-7. PubMed ID: 20734877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988.
    Huddart SN; Mann JR; Gornall P; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendsus KR
    J Pediatr Surg; 1990 Apr; 25(4):406-10. PubMed ID: 1691781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome.
    Ong TA; Winkler MH; Savage PM; Seckl MJ; Christmas TJ
    BJU Int; 2008 Jul; 102(2):198-202. PubMed ID: 18294302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor.
    Barragán-Carrillo R; Mateos-Corella S; Ortiz-Hidalgo C; Izquierdo-Echavarri E; Castillejos-Molina R; Angel M; Barragan-Arteaga I; Flaig T; Bourlon MT
    Oncology (Williston Park); 2021 Dec; 35(12):816-819. PubMed ID: 35088997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
    Aass N; Klepp O; Cavallin-Stahl E; Dahl O; Wicklund H; Unsgaard B; Baldetorp L; Ahlström S; Fosså SD
    J Clin Oncol; 1991 May; 9(5):818-26. PubMed ID: 1707957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
    Fosså SD; Qvist H; Stenwig AE; Lien HH; Ous S; Giercksky KE
    J Clin Oncol; 1992 Apr; 10(4):569-73. PubMed ID: 1312586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical usefulness of serum ferritin measurements in patients with testicular germ cell tumors.
    Szymendera JJ; Kozłowicz-Gudzinska I; Madej G; Sikorowa L; Kaminska JA; Kowalska M
    Oncology; 1985; 42(4):253-8. PubMed ID: 2409496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
    J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mixed germ cell testicular tumor presenting as metastatic cutaneous choriocarcinoma.
    Bonilla L; Harris A; McGarry K; Dyer RK; Telang G; Robinson-Bostom L
    J Am Acad Dermatol; 2011 Aug; 65(2):455-456. PubMed ID: 21763587
    [No Abstract]   [Full Text] [Related]  

  • 51. Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors.
    Nayan M; Jewett MA; Sweet J; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Hamilton RJ
    J Urol; 2015 Aug; 194(2):386-91. PubMed ID: 25823792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between primary and metastatic testicular germ cell tumors: a clinicopathologic analysis of 100 cases.
    Tarrant WP; Czerniak BA; Guo CC
    Hum Pathol; 2013 Oct; 44(10):2220-6. PubMed ID: 23856516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical outcome of adult testicular tumor. I. Study on patients of nonseminoma with negative human chorionic gonadotropin].
    Kawai T; Sakuramoto T; Kihara K
    Hinyokika Kiyo; 1984 May; 30(5):627-37. PubMed ID: 6089532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intratubular trophoblasts in the contralateral testis caused elevation of serum human chorionic gonadotropin following complete remission of stage II testicular tumor: a case report.
    Nitta S; Kawai K; Onozawa M; Ando S; Miyazaki J; Nagata C; Noguchi M; Yamasaki K; Uchida K; Iwamoto T; Nishiyama H
    Jpn J Clin Oncol; 2013 Jan; 43(1):83-6. PubMed ID: 23136239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retroperitoneal lymph node dissection in clinical stage IIA and IIB nonseminomatous germ cell tumours of the testis.
    Pizzocaro G
    Int J Androl; 1987 Feb; 10(1):269-75. PubMed ID: 3034796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.
    Masterson TA; Carver BS; Shayegan B; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
    Urology; 2012 May; 79(5):1079-84. PubMed ID: 22446341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.